Arsenic-Induced Carcinogenicity: New Insights in Molecular Mechanism

Metal Complex-DNA Interactions

Volumn , Issue , 2009, Pages 491-510

  Hartwig, Andrea ^a   Schwerdtle, Tanja ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Altered DNA methylation and carcinogenicity; Arsenic induced carcinogenicity new insights in molecular mechanism; Carcinogenicity and cocarcinogenicity; Inorganic arsenic metabolism; Major mechanisms in arsenic induced carcinogenicity; P53 guarding role in genome integrity; Reactive oxygen (ROS) and nitrogen species (RNS) in arsenic response

Indexed keywords

EID: 80052306598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312089.ch18     Document Type: Chapter

References (142)

1. ATSDR; Toxicological Profile For Arsenic; Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service 2000.
2. ATSDR; Toxicological Profile for Arsenic; Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service 2007.
3. Chou, C.H.; De Rosa, C.T.; Case studies-arsenic; Int. J. Hyg. Environ. Health 2003, 206, 381-386.
4. National Research Council; Arsenic in drinking water; Washington D.C.; National Academy Press; 1999.
5. National Research Council; Arsenic in drinking water 2001 update; Washington D.C.; National Academy Press; 2001.
6. Yoshida, T.; Yamauchi, H.; Fan Sun, G.; Chronic health effects in people exposed to arsenic via the drinking water;dose-response relationships in review; Toxicol. Appl. Pharmacol. 2004, 198, 243-252.
7. IARC; Arsenic and Arsenic compounds; Lyon 1980.
8. IARC; Arsenic and Arsenic compounds (Group 1) 1987.
9. Greim, H. (ed); The MAK-Collectionfor Occupational Health and Safety; MAK Value Documentations; Arsenic and its inorganic compounds (except arsine); Wiley-VCH; Weinheim; 2002, 21, 49-106.
10. WHO; Arsenic and arsenic compounds; Genf 2001.
11. DFG; Deutsche Forschungsgemeinschaft; List of MAK and BAT values 2008; Report No. 44; Wiley-VCH; Weinheim; 2008.
12. Waalkes, M.P.; Liu, J.; Ward, J.M.; Diwan, B.A.; Animal models for arsenic carcinogenesis;inorganic arsenic is a transplacental carcinogen in mice; Toxicol. Appl. Pharmacol. 2004, 198, 377-384.
13. Wang, J.P.; Qi, L.; Moore, M.R.; Ng, J.C.; A review of animal models for the study of arsenic carcinogenesis; Toxicol. Lett. 2002, 133, 17-31.
14. Waalkes, M.P.; Liu, J.; Diwan, B.A.; Transplacental arsenic carcinogenesis in mice; Toxicol. Appl. Pharmacol. 2007, 222, 271-280.
15. Pershagen, G.; Nordberg, G.; Bjorklund, N.E.; Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo[a]pyrene by the pulmonary route; Environ. Res. 1984, 34, 227-241.
16. Rossman, T.G.; Uddin, A.N.; Burns, F.J.; Bosland, M.C.; Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin;an animal model for arsenic carcinogenesis; Toxicol. Appl. Pharmacol. 2001, 176, 64-71.
17. Burns, F.J.; Uddin, A.N.; Wu, F.; Nadas, A.; Rossman, T.G.; Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin;a dose-response study; Environ. Health Perspect. 2004, 112, 599-603.
18. Chiou, H.Y.; Hsueh, Y.M.; Liaw, K.F.; Horng, S.F.; Chiang, M.H.; Pu, Y.S.;et al, Incidence of internal cancers and ingested inorganic arsenic;a seven-year follow-up study in Taiwan; Cancer Res. 1995, 55, 1296-1300.
19. Tsuda, T.; Babazono, A.; Yamamoto, E.; Kurumatani, N.; Mino, Y.; Ogawa, T.; et al., Ingested arsenic and internal cancer;a historical cohort study followed for 33 years; Am. J. Epidemiol. 1995, 141, 198-209.
20. Rossman, T.G.; Uddin, A.N.; Burns, F.J.; Evidence that arsenite acts as a cocarcinogen in skin cancer; Toxicol. Appl. Pharmacol. 2004, 198, 394-404.
21. Kenyon, E.M.; Hughes-M.F.; A concise review of the toxicity and carcinogenicity of dimethylarsinic acid; Toxicology 2001, 160, 227-236.
22. Kitchin, K.T.; Recent advances in arsenic carcinogenesis;modes of action, animal model systems, and methylated arsenic metabolites; Toxicol. Appl. Pharmacol. 2001, 172, 249-261.
23. Pott, W.A.; Benjamin, S.A.; Yang, R.S.; Pharmacokinetics, metabolism, and carcinogenicity of arsenic; Rev. Environ. Contam. Toxicol. 2001, 169, 165-214.
24. Thomas, D.J.; Molecular processes in cellular arsenic metabolism; Toxicol. Appl. Pharmacol. 2007, 222, 365-373.
25. Aposhian, V.H.; Zakharyan, R.A.; Avram, M.D.; Sampayo-Reyes, A.; Wollenber, g M.L.; A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species; Toxicol. Appl. Pharmacol. 2004, 198, 327-335.
26. Aposhian, H.V.; Aposhian, M.M.; Arsenic toxicology: five questions; Chem. Res. Toxicol. 2006, 19, 1-15.
27. Cullen, W.R.; Reimer, K.J.; Arsenic speciation in the environment; Chemical Reviews (Washington DC, United States) 1989, 89, 713-764.
28. Hayakawa, T.; Kobayashi, Y.; Cui, X.; Hirano, S.; A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cytl9; Arch. Toxicol. 2005, 79, 508-518.
29. Naranmandura, H.; Suzuki, N.; Suzuki, K.T.; Trivalent arsenicals are bound to proteins during reductive methylation; Chem. Res. Toxicol. 2006, 19, 1010-1018.
30. Hartwig, A.; Blessing, H.; Schwerdtle, T.; Walter, I.; Modulation of DNA repair processes by arsenic and selenium compounds; Toxicology 2003, 193, 161-169.
31. Kumagai, Y.; Sumi, D.; Arsenic; signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity; Annu. Rev. Pharmacol. Toxicol. 2007; 47, 243-262.
32. Kligerman, A.D.; Tennant, A.H.; Insights into the carcinogenic mode of action of arsenic; Toxicol. Appl. Pharmacol. 2007, 222, 281-288.
33. Hughes, M.F.; Arsenic toxicity and potential mechanisms of action; Toxicol. Lett. 2002, 133, 1-16.
34. Huang, C.; Ke, Q.; Costa, M.; Shi, X.; Molecular mechanisms of arsenic carcinogenesis; Mol. Cell. Biochem. 2004, 255, 57-66.
35. Shi, H.; Shi, X.; Liu, K.J.; Oxidative mechanism of arsenic toxicity and carcinogenesis; Mol. Cell. Biochem. 2004, 255, 67-78.
36. Schoen, A.; Beck, B.; Sharma, R.; Dube, E.; Arsenic toxicity at low doses;epidemiological and mode of action considerations; Toxicol. Appl. Pharmacol. 2004, 198, 253-267.
37. Gebel, T.W.; Genotoxicity of arsenical compounds; Int. J. Hyg. Environ. Health 2001, 203, 249-262.
38. Hei, T.K.; Liu, S.X.; Waldren; C.; Mutagenicity of arsenic in mammalian cells;role of reactive oxygen species; Proc. Natl. Acad. Sci. USA 1998, 95, 8103-8107.
39. Li, Y.M.; Broome, J.D.; Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells; Cancer Res. 1999, 59, 776-780.
40. Lee, T.C.; Tanaka, N.; Lamb, P.W.; Gilmer, T.M.; Barrett, J.C.; Induction of gene amplification by arsenic; Science 1988, 241, 79-81.
41. Schwerdtle, T.; Walter, I.; Mackiw, I.; Hartwig, A.; Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA; Carcinogenesis 2003, 24, 967-974.
42. Schwerdtle, T.; Walter, I., Hartwig, A.; Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg; DNA Repair (Amst) 2003, 2, 1449-1463.
43. Wang, T.S.; Chung, C.H.; Wang, A.S.; Bau, D.T.; Samikkannu, T.; Jan, K.Y.; et al., Endonuclease III, formamidopyrimidine-DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells; Chem. Res. Toxicol. 2002, 15, 1254-1258.
44. Mass, M.J.; Tennant, A.; Roop, B.C.; Cullen, W.R.; Styblo, M.; Thomas, D.J.; et al., Methylated trivalent arsenic species are genotoxic; Chem. Res. Toxicol. 2001, 14, 355-361.
45. Kligerman, A.D.; Doerr, C.L.; Tennant, A.H.; Harrington-Brock, K.; Allen, J.W.; Winkfield, E.; et al.; Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations; Environ. Mol. Mutagen. 2003, 42, 192-205.
46. Rossman, T.G.; Molina, M.; Klein, C.B.; Comutagens in E; Coli and chinese hamster cells with special attention to arsenite; 1985.
47. Okui, T.; Fujiwara, Y.; Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells; Mutat. Res. 1986, 172, 69-76.
48. Li, J.H.; Rossman, T.G.; Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells; Biol. Met. 1991, 4, 197-200.
49. Maier, A.; Schumann, B.L.; Chang, X.; Talaska, G.; Puga, A.; Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity; Mutat. Res. 2002, 517, 101-111.
50. Lewinska, D.; Arkusz, J.; Stanczyk, M.; Palus, J.; Dziubaltowska, E.; Stepnik, M.; Comparison of the effects of arsenic and cadmium on benzo(a)pyrene-induced micronuclei in mouse bone-marrow; Mutat. Res. 2007, 632, 37-43.
51. Wiencke, J.K.; Yager, J.W.; Varkonyi, A.; Hultner, M.; Lutze, L.H.; Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells; Mutat. Res. 1997, 386, 335-344.
52. Beyersmann, D.; Hartwig, A.; Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms; Arch. Toxicol. 2008, 82, 493-512.
53. Ostrosky-Wegman, P.; Gonsebatt, M.E.; Montero, R.; Vega, L.; Barba, H.; Espinosa, J.; et al., Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico; Mutat. Res. 1991, 250, 477-482.
54. Lerda, D.; Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water; Mutat. Res. 1994, 312, 111-120.
55. Warner, M.L.; Moore, L.E.; Smith, M.T.; Kalman, D.A.; Fanning, E.; Smith, A.H.; Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol. Biomarkers Prev. 1994, 3, 583-590.
56. Dulout, F.N.; Grillo, C.A.; Seoane, A.I.; Maderna, C.R.; Nilsson, R.; Vahter, M.; et al., Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water; Mutat. Res. 1996, 370, 151-158.
57. Gonsebatt, M.E.; Vega, L.; Salazar, A.M.; Montero, R.; Guzman, P.; Blas, J.; et al., Cytogenetic effects in human exposure to arsenic; Mutat. Res. 1997, 386, 219-228.
58. Moore, L.E.; Smith, A.H.; Hopenhayn-Rich, C.; Biggs, M.L.; Kalman, D.A.; Smith, M.T.; Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water; Cancer Epidemiol. Biomarkers Prev. 1997, 6, 31-36.
59. Maki-Paakkanen, J.; Kurttio, P.; Paldy, A.; Pekkanen, J.; Association between the clas-togenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water; Environ. Mol. Mutagen. 1998, 32, 301-313.
60. Tian, D.; Ma, H.; Feng, Z.; Xia, Y.; Le, X.C.; Ni, Z.; et al.; Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in inner Mongolia, China. J. Toxicol. Environ. Health A 2001, 64, 473-484.
61. Basu, A.; Mahata, J.; Roy, A.K.; Sarkar, J.N.; Poddar, G.; Nandy, A.K.; et al., Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India; Mutat. Res. 2002, 516, 29-40.
62. Mahata, J.; Basu, A.; Ghoshal, S.; Sarkar, J.N.; Roy, A.K.; Poddar, G.; et al., Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India; Mutat. Res. 2003, 534, 133-143.
63. Basu, A.; Ghosh, P.; Das, J.K.; Banerjee, A.; Ray, K.; Giri, A.K.; Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types; Cancer Epidemiol. Biomarkers Prev. 2004, 13, 820-827.
64. Mahata, J.; Chaki, M.; Ghosh, P.; Das, L.K.; Baidya, K.; Ray, K.; et al., Chromosomal aberrations in arsenic-exposed human populations;a review with special reference to a comprehensive study in West Bengal, India; Cytogenet. Genome. Res. 2004, 104, 359-364.
65. Martinez, V.; Creus, A.; Venegas, W.; Arroyo, A.; Beck, J.P.; Gebel, T.W.; et al., Evaluation of micronucleus induction in a Chilean population environmentally exposed to arsenic; Mutat. Res. 2004, 564, 65-74.
66. Martinez, V.; Creus, A.; Venegas, W.; Arroyo, A.; Beck, J.P.; Gebel, T.W.; et al., Micronuclei assessment in buccal cells of people environmentally exposed to arsenic in northern Chile; Toxicol. Lett. 2005, 155, 319-327.
67. Ghosh, P.; Basu, A.; Mahata, J.; Basu, S.; Sengupta, M.; Das, J.K.; et al., Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-mduced cancer through drinking water; Int. J. Cancer 2006, 118, 2470-2478.
68. Kumagai, Y.; Pi, J.; Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress;implication of endothelial dysfunction; Toxicol. Appl. Pharmacol. 2004, 198, 450-457.
69. Hughes, M.F.; Kitchin, K.T.; Arsenic, oxidative stress and carcniogenesis; In;Singh HH, editor; Oxidative Stress, Disease and Cancer; London; Imperial College Press; 2006, 2006-825.
70. Lynn, S.; Gurr, J.R.; Lai, H.T.; Jan, K.Y.; NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells; Circ. Res. 2000, 86, 514-519.
71. Corsini, E.; Asti, L.; Viviani, B.; Marinovich, M.; Galli, C.L.; Sodium arsenate induces overproduction of interleukin11 alpha in murine keratinocytes: role of mitochondria; J. Invest. Dermatol. 1999, 113, 760-765.
72. Yamanaka, K.; Hoshino, M.; Okamoto, M.; Sawamura, R.; Hasegawa, A.; Okada, S.; Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical; Biochem. Biophys. Res. Commun. 1990, 168, 58-64.
73. Yamanaka, K.; Kato, K.; Mizoi, M.; An, Y.; Takabayashi, F.; Nakano, M.; et al., The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis; Toxicol. Appl. Pharmacol. 2004, 198, 385-393.
74. Yamanaka, K.; Hasegawa, A.; Sawamura, R.; Okada, S.; Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice; Toxicol. Appl. Pharmacol. 1991, 108, 205-213.
75. Yamanaka, K.; Okada, S.; Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals; Environ. Health Perspect. 1994, 102 Suppl 3, 37-40.
76. Yamanaka, K.; Hayashi, H.; Tachikawa, M.; Kato, K.; Hasegawa, A.; Oku, N.; et al., Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics; Mutat. Res. 1997, 394, 95-101.
77. Yamanaka, K.; Katsumata, K.; Ikuma, K.; Hasegawa, A.; Nakano, M.; Okada, S.; The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-i nduced skin tumorigenesis in hairless mice; Cancer Lett. 2000, 152, 79-85.
78. Yamanaka, K.; Takabayashi, F.; Mizoi, M.; An, Y.; Hasegawa, A.; Okada, S.; Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis; Biochem. Biophys. Res. Commun. 2001, 287, 66-70.
79. Yamanaka, K.; Mizoi, M.; Tachikawa, M.; Hasegawa, A.; Hoshino, M., Okada, S.; Oxidative DNA damage following exposure to dimethylarsinous iodide;the formation of cis-thymine glycol; Toxicol. Lett. 2003, 143, 145-153.
80. Ahmad, S.; Kitchin, K.T.; Cullen, W.R.; Arsenic species that cause release of iron from ferritin and generation of activated oxygen; Arch. Biochem. Biophys. 2000, 382, 195-202.
81. Ahmad, S.; Kitchin, K.T.; Cullen, W.R.; Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin; Toxicol. Lett. 2002, 133, 47-57.
82. Li, B.; Sun, Y.; Sun, X.; Wang, Y.; Li, X.; Kumagai, Y.; et al., Monomethylarsonous acid induced cytotoxicity and endothelial nitric oxide synthase phosphorylation in endothelial cells; Bull. Environ. Contam. Toxicol. 2007, 78, 455-458.
83. Epe, B.; Role of endogenous oxidative DNA damage in carcinogenesis; what can we learn from repair-deficient mice? Biol. Chem. 2002, 383, 467-475.
84. Chouchane, S.; Snow, E.T.; In vitro effect of arsenical compounds on glutathione-related enzymes; Chem. Res. Toxicol. 2001, 14, 517-522.
85. Styblo, M.; Serves, S.V.; Cullen, W.R.; Thomas, D.J.; Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols; Chem. Res. Toxicol. 1997, 10, 27-33.
86. Bau, D.T.; Gurr, J.R.; Jan, K.Y.; Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision; Carcinogenesis 2001, 22, 709-716.
87. Snow, E.T.; Sykora, P.; Durham, T.R.; Klein, C.B.; Arsenic, mode of action at biologically plausible low doses; What are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol. 2005, 207, 557-564.
88. Li, M.; Cai, J.F.; Chiu, J.F.; Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells; J. Cell. Biochem. 2002, 87, 29-38.
89. Sykora, P.; Snow, E.T.; Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite; Toxicol. Appl. Pharmacol. 2008, 228, 385-394.
90. Leonard, S.S.; Harris, G.K.; Shi, X.; Metal-induced oxidative stress and signal transduction; Free. Radic. Biol. Med. 2004, 37, 1921-1942.
91. Kubota, R.; Kunito, T.; Agusa, T.; Fujihara, J.; Monirith, I.; Iwata, H.; et al., Urinary 8-hydroxy-2'-deoxyguanosine in inhabitants chronically exposed to arsenic in groundwater in Cambodia; J. Environ. Monit. 2006, 8, 293-299.
92. Mo, J.; Xia, Y.; Wade, T.J.; Schmitt, M.; Le, X.C.; Dang, R.; et al., Chronic arsenic exposure and oxidative stress, OGG1 expression and arsenic exposure, nail selenium, and skin hyperkeratosis in Inner Mongolia; Environ. Health Perspect. 2006, 114, 835-841.
93. Basu, A.; Som, A.; Ghoshal, S.; Mondal, L.; Chaubey, R.C.; Bhilwade, H.N.; et al., Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal, India; Toxicol. Lett. 2005, 159, 100-112.
94. Fujino, Y.; Guo, X.; Liu, J.; Matthews, I.P.; Shirane, K.; Wu, K.; et al., Chronic arsenic exposure and urinary 8-hydroxy-2'-deoxyguanosine in an arsenic-affected area in Inner Mongolia, China; J. Expo. Anal. Environ. Epidemiol. 2005, 15, 147-152.
95. Pi, J.; Yamauchi, H.; Kumagai, Y.; Sun, G.; Yoshida, T.; Aikawa, H.; et al., Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water; Environ. Health Perspect. 2002, 110, 331-336.
96. Wu, M.M.; Chiou, H.Y.; Wang, T.W.; Hsueh, Y.M.; Wang, I.H.; Chen, C.J.; et al, Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan; Environ. Health Perspect. 2001, 109, 1011-1017.
97. Breton, C.V.; Kile, M.L.; Catalano, P.J.; Hoffman, E.; Quamruzzaman, Q.; Rahman, M.; et al., GSTM1 and APE1 genotypes affect arsenic-induced oxidative stress: a repeated measures study; Environ. Health 2007, 6, 39.
98. Baylin, S.B.; Belinsky, S.A.; Herman, J.G.; Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise; J. Natl. Cancer Inst. 2000, 92, 1460-1461.
99. Baylin, S.B.; Herman, J.G.; DNA hypermethylation in tumorigenesis;epigenetics joins genetics; Trends. Genet. 2000, 16, 168-174.
100. Mass, M.J.; Wang, L.; Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis; Mutat. Res. 1997, 386, 263-277.
101. Zhong, C.X.; Mass, M.J.; Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR; Toxicol. Lett. 2001, 122, 223-234.
102. Zhao, C.Q.; Young, M.R.; Diwan, B.A.; Coogan, T.P.; Waalkes, M.P.; Association of arsenic--nduced malignant transformation with DNA hypomethylation and aberrant gene expression; Proc. Natl. Acad. Sci. USA 1997, 94, 10907-10912.
103. Reichard, J.F.; Schnekenburger, M.; Puga, A.; Long term low-dose arsenic exposure induces loss of DNA methylation; Biochem. Biophys. Res. Commun. 2007, 352, 188-192.
104. INK4a and RASSF1A and induces lung cancer in A/J mice; Toxicol. Sci. 2006, 91, 372-381.
105. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, et al., DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol. Sci. 2006; 89: 431-437.
106. Marsit, C.J.; Karagas, M.R.; Danaee, H.; Liu, M.; Andrew, A.; Schned, A.; et al., Carcinogen exposure and gene promoter hypermethylation in bladder cancer; Carcinogenesis 2006, 27, 112-116.
107. Huen, M.S.; Chen, J.; The DNA damage response pathways: at the crossroad of protein modifications; Cell. Res. 2008, 18, 8-16.
108. Friedberg, E.C.; Walker, G.C.; Siede, W.; Wood, R.D.; Schultz, R.A.; Ellenberger, T.; DNA Repair and Mutagenesis; Second Edition; Washington; ASM Press; 2006.
109. Friedberg, E.C.; A brief history of the DNA repair field. Cell. Res. 2008, 18, 3-7.
110. Hakem, R.; DNA-damage repair;the good, the bad, and the ugly; EMBO J. 2008, 27, 589-605.
111. Lee-Chen, S.F.; Yu, C.T.; Jan, K.Y.; Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells; Mutagenesis 1992, 7, 51-55.
112. Wang, T.C.; Huang, J.S.; Yang, V.C.; Lan, H.J.; Lin, C.J.; Jan, K.Y.; Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite; Int. J. Radiat. Biol. 1994, 66, 367-372.
113. Hartwig, A.; Gröblinghoff, U.D.; Beyersmann, D.; Natarajan, A.T.; Filon, R.; Mullenders, L.H.; Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts; Carcinogenesis 1997, 18, 399-405.
114. Tran, H.P.; Prakash, A.S.; Barnard, R.; Chiswell, B.; Ng, J.C.; Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene; Toxicol. Lett. 2002, 133, 59-67.
115. Danaee, H.; Nelson, H.H.; Liber, H.; Little, J.B.; Kelsey, K.T.; Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells; Mutagenesis 2004, 19, 143-148.
116. Shen, S.; Lee, J.; Weinfeld, M.; Le, X.C.; Attenuation of DNA damage-induced p53 expression by arsenic;A possible mechanism for arsenic co-carcinogenesis; Mol. Carcinog. 2008, 47, 508-518.
117. Hartmann, A.; Speit, G.; Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells; Environ. Mol. Mutagen. 1996, 27, 98-104.
118. Fousteri, M.; Mullenders, L.H.; Transcription-coupled nucleotide excision repair in mammalian cells;molecular mechanisms and biological effects; Cell. Res. 2008, 18, 73-84.
119. Kitchin, K.T.; Wallace, K.; The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity; J. Inorg. Biochem. 2008, 102, 532-539.
120. Piatek, K.; Schwerdtle, T.; Hartwig, A.; Bal, W.; Monomethylarsonous Acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite;mechanistic considerations and consequences for DNA repair inhibition; Chem. Res. Toxicol. 2008, 21, 600-606.
121. Asmuss, M.; Mullenders, L.H.; Eker, A.; Hartwig, A.; Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair; Carcinogenesis 2000, 21, 2097-2104.
122. Mustra, D.J.; Warren, A.J.; Wilcox, D.E.; Hamilton, J.W.; Preferential binding of human XPA to the mitomycin C-DNA interstrand crosslink and modulation by arsenic and cadmium; Chem. Biol. Interact. 2007, 168, 159-168.
123. Hartwig, A.; Pelzer, A.; Asmuss, M.; Bürkle, A.; Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells; Int. J. Cancer 2003, 104, 1-6.
124. Walter, I.; Schwerdtle, T.; Thuy, C.; Parsons, J.L.; Dianov, G.L.; Hartwig, A.; Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells; DNA Repair (Amst) 2007, 6, 61-70.
125. Bürkle, A.; Brabeck, C.; Diefenbach, J.; Beneke, S.; The emerging role of poly(ADP-ribose) polymerase-1 in longevity; Int. J. Biochem. Cell. Biol. 2005, 37, 1043-1053.
126. Poonepalli, A.; Balakrishnan, L.; Khaw, A.K.; Low, G.K.; Jayapal, M.; Bhattacharjee, R.N.; et al., Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite; Cancer Res. 2005, 65, 10977-10983.
127. Li, J.H.; Rossman, T.G.; Inhibition of DNA ligase activity by arsenite;a possible mechanism of its comutagenesis; Mol. Toxicol. 1989, 2, 1-9.
128. Hu, Y.; Su, L.; Snow, E.T.; Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes; Mutat. Res. 1998, 408, 203-218.
129. Yih, L.H.; Lee, T.C.; Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts; Cancer Res. 2000, 60, 6346-6352.
130. Menendez, D.; Mora, G.; Salazar, A.M.; Ostrosky-Wegman, P.; ATM status confers sensitivity to arsenic cytotoxic effects; Mutagenesis 2001, 16, 443-448.
131. Tang, F.; Liu, G.; He, Z.; Ma, W.Y.; Bode, A.M.; Dong, Z.; Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells; Mol. Carcinog. 2006, 45, 861-870.
132. Chai, C.Y.; Huang, Y.C.; Hung, W.C.; Kang, W.Y.; Chen, W.T.; Arsenic salt-induced DNA damage and expression of mutant p53 and COX~2 proteins in SV-40 immortalized human uroepithelial cells. Mutagenesis 2007, 22, 403-408.
133. Butler, J.S.; Loh, S.N.; Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain; Biochemistry 2003, 42, 2396-2403.
134. Wang, P.L.; Sait, F.; Winter, G.; The 'wildtype' conformation of p53: epitope mapping using hybrid proteins; Oncogene. 2001, 20, 2318-2324.
135. Martin, A.C.; Facchiano, A.M.; Cuff, A.L.; Hernandez-Boussard, T.; Olivier, M.; Hainaut, P.; et al., Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein; Hum. Mutat. 2002, 19, 149-164.
136. Hamadeh, H.K.; Trouba, K.J.; Amin, R.P.; Afshari, C.A.; Germolec, D.; Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes; Toxicol. Sci. 2002, 69, 306-316.
137. Andrew, A.S.; Warren, A.J.; Barchowsky, A.; Temple, K.A.; Klei, L.; Soucy, N.V.; et al., Genomic and proteomic profiling of responses to toxic metals in human lung cells; Environ. Health Perspect. 2003, 111, 825-835.
138. Nollen, M.; Ebert, F.; Moser, J.; Mullenders, L.H.; Hartwig, A.; Schwerdtle, T.; Impact of arsenic on nucleotide excision repair;XPC function, protein level and gene expression; Molecular Nutrition and Food Research, 2008, submitted.
139. Andrew, A.S.; Burgess, J.L.; Meza, M.M.; Demidenko, E.; Waugh, M.G.; Hamilton, J.W.; et al., Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic; Environ. Health Perspect., 2006, 114, 1193-1198.
140. Andrew, A.S.; Karagas, M.R.; Hamilton, J.W.; Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water; Int. J. Cancer, 2003, 104, 263-268.
141. Banerjee, M.; Sarma, N.; Biswas, R.; Roy, J.; Mukherjee, A.; Giri, A.K.; DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions; Int. J. Cancer, 2008, 123, 283-287.
142. Yager, J.W.; Wiencke, J.K.; Inhibition of poly(ADP-ribose) polymerase by arsenite; Mutat. Res., 1997, 386, 345-351.